Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Alterity Therapeutics ( (AU:ATH) ) has shared an announcement.
Alterity Therapeutics Limited has announced the appointment of Julian Barbaczy as a director, effective November 21, 2025. The initial director’s interest notice indicates that Barbaczy does not hold any relevant interests in securities as a registered or non-registered holder, nor does he have any interests in contracts related to the company. This announcement is part of the company’s compliance with listing rules and corporate governance practices, ensuring transparency and accountability in its management structure.
More about Alterity Therapeutics
Average Trading Volume: 14,994,693
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$97.88M
For an in-depth examination of ATH stock, go to TipRanks’ Overview page.